streptococcu
pneumonia
major
caus
human
diseas
estim
million
peopl
includ
children
age
die
everi
year
pneumococc
infect
addit
role
lead
caus
communityacquir
pneumonia
pneumonia
caus
agent
varieti
infect
includ
otiti
media
blood
stream
infect
spontan
periton
mening
pneumococc
mening
form
pneumococc
diseas
associ
signific
mortal
morbid
children
develop
countri
pneumococc
mening
mortal
rate
associ
risk
sequela
develop
countri
mortal
morbid
rate
much
higher
pneumonia
belong
miti
subgroup
alphahaemolyt
viridan
streptococci
vg
miti
group
streptococci
pneumonia
also
associ
bacteraemia
may
clinic
nonsignific
may
also
associ
invas
diseas
particularli
predispos
patient
immunocompromis
cardiac
valv
damag
miti
group
organ
miti
orali
pseudopneumonia
possess
rrna
sequenc
homolog
pneumonia
furthermor
horizont
gene
transfer
streptococci
give
rise
atyp
streptococci
difficult
classifi
use
phenotyp
method
given
close
genotyp
phenotyp
relationship
miti
group
streptococci
differenti
pneumococcu
vg
challeng
cultur
base
method
gold
standard
diagnos
invas
pneumococc
diseas
ipd
howev
cultur
base
method
typic
requir
least
sever
hour
day
incub
organ
detect
furthermor
method
often
demonstr
limit
diagnost
sensit
particularli
post
antibiot
treatment
case
low
sampl
volum
often
case
children
molecular
amplif
method
pcr
loopmedi
isotherm
amplif
lamp
use
diagnos
ipd
method
report
sensit
reliant
viabl
organ
potenti
deliv
rapid
result
recombinas
polymeras
amplif
rpa
isotherm
vitro
nucleic
acid
amplif
technolog
use
combin
recombinas
protein
oligonucleotid
primer
strand
displac
polymeras
amplifi
dna
sequenc
rpa
sensit
rapid
specif
robust
less
sensit
inhibitor
pcr
rpa
appli
detect
wide
varieti
bacteri
viral
eukaryot
molecular
target
use
fluoresc
probe
enabl
monitor
reaction
realtim
multiplex
capabl
isotherm
amplif
strategi
great
interest
molecular
diagnost
negat
need
thermocycl
case
pcr
isotherm
natur
techniqu
make
suitabl
incorpor
devic
capabl
deploy
pointofcar
molecular
target
use
identifi
pneumonia
includ
varieti
gene
includ
fragment
reca
gene
rrna
gene
virul
factor
gene
autolysin
lyta
pneumolysin
pli
whilst
target
proven
use
detect
pneumonia
abil
unequivoc
identifi
pneumonia
remain
problemat
exampl
fals
posit
occur
lyta
marker
pli
associ
fals
neg
result
leader
peptidas
lepa
also
known
elong
factor
one
conserv
bacteri
protein
found
virtual
know
genom
function
ribosom
depend
gtpase
abil
backtransloc
posttransloc
ribosom
increas
activ
fraction
newli
translat
protein
util
diagnost
marker
previous
demonstr
multiplex
assay
detect
mycobacterium
tuberculosi
complex
mtc
studi
develop
perform
preliminari
evalu
realtim
rpa
assay
base
lepa
gene
detect
pneumonia
also
develop
lepa
base
pneumonia
realtim
pcr
assay
compar
term
specif
sensit
pneumonia
bacteri
refer
strain
n
non
pneumonia
refer
strain
n
invas
pneumonia
clinic
isol
n
evalu
studi
tabl
strain
cultur
overnight
brain
heart
infus
bhi
medium
oxoid
uk
enumer
serial
dilut
bacteri
suspens
spread
plate
columbia
blood
agar
incub
hr
follow
overnight
cultur
bacteri
genom
dna
extract
purifi
use
dneasi
blood
tissu
kit
qiagen
germani
accord
manufactur
instruct
follow
purif
dna
quantifi
fluoresc
qubit
dna
br
assay
life
technolog
uk
genom
equival
ge
calcul
base
assum
genom
size
mb
whole
blood
spike
experi
overnight
cultur
cultur
medium
serial
dilut
bhi
serial
dilut
bacteri
suspens
spike
fresh
human
whole
blood
subsequ
total
genom
dna
extract
purifi
use
dneasi
blood
tissu
kit
qiagen
germani
accord
manufactur
instruct
except
dna
elut
rather
buffer
ae
lepa
sequenc
obtain
genbank
http
wwwncbinlmnihgovgenbank
function
gene
pipelin
repositori
fungen
http
fungenecmemsuedu
websit
sequenc
align
use
multipl
sequenc
align
tool
clustalw
follow
align
pneumonia
specif
pcr
rpa
primer
probe
manual
design
tabl
sequenc
final
screen
homolog
use
blastn
algorithm
http
blastncbinlmnihgovblastcgi
confirm
specif
oligonucleotid
primer
probe
purchas
integr
dna
technolog
leuven
belgium
except
rpa
probe
purchas
biosearch
technolog
petaluma
california
usa
rpa
reaction
perform
use
twistamp
kit
twistdx
cambridg
uk
contain
x
rehydr
buffer
forward
revers
primer
probe
genom
dna
amplif
templat
initi
reaction
mm
magnesium
acet
concentr
mm
ad
reaction
perform
total
volum
portabl
realtim
fluoromet
twistdx
minut
mix
centrifug
step
first
minut
extern
neg
posit
amplif
control
includ
run
posit
amplif
control
consist
ge
pneumonia
type
strain
dsm
dilut
molecular
grade
water
notempl
control
ntc
consist
molecular
grade
water
realtim
pcr
assay
perform
use
realtim
pcr
instrument
roch
diagnost
uk
pcr
reaction
perform
optic
strip
bioplast
bv
netherland
total
volum
reaction
consist
x
lightcycl
probe
master
mix
roch
diagnost
uk
primer
probe
genom
dna
amplif
templat
neg
posit
amplif
control
includ
run
posit
amplif
control
consist
ge
pneumonia
type
strain
dsm
dilut
molecular
grade
water
templat
control
ntc
consist
molecular
grade
water
cycl
paramet
consist
cycl
follow
cycl
specif
rpa
pcr
assay
evalu
genom
dna
ge
panel
streptococcu
nonstreptococcu
organ
see
tabl
test
rpa
pcr
amplif
assay
analyt
limit
detect
confid
level
pcr
rpa
assay
determin
pneumonia
dsm
genom
dna
dilut
molecular
grade
water
ge
per
microlit
pcr
rpa
reaction
perform
use
dilut
dna
amplif
templat
reaction
perform
replic
twelv
subsequ
data
analys
statist
probit
minitab
version
order
determin
limit
background
human
dna
toler
rpa
pcr
reaction
vari
quantiti
human
genom
dna
ng
ad
reaction
contain
pneumonia
dsm
ge
human
whole
blood
collect
healthi
volunt
edta
vacutain
becton
dickinson
compani
ireland
two
microlit
serial
dilut
bacteri
suspens
five
order
magnitud
spike
fresh
within
hr
sampl
human
whole
blood
aliquot
serial
dilut
bacteri
suspens
plate
blood
agar
enumer
spike
blood
sampl
process
immedi
extract
dna
elut
dna
subject
rpa
pcr
amplif
whole
blood
collect
edta
blood
tube
patient
attend
galway
univers
hospit
suspect
bloodstream
infect
routin
full
blood
count
healthi
volunt
gener
within
hour
collect
patient
blood
residu
materi
collect
anonymis
store
blood
collect
healthi
volunt
also
store
subsequ
sampl
thaw
ice
total
genom
dna
extract
sampl
elut
molecular
grade
water
describ
previous
analysi
elut
genom
dna
subject
amplif
rpa
pcr
ethic
approv
studi
grant
ethic
committe
galway
univers
hospit
galway
ireland
particip
select
basi
blood
cultur
submit
depart
medic
microbiolog
detect
blood
stream
infect
follow
full
blood
count
patient
residu
edta
blood
sampl
avail
recruit
studi
base
result
blood
cultur
confirm
posit
presenc
pneumonia
control
blood
collect
healthi
individu
follow
inform
consent
analyt
specif
rpa
realtim
pcr
assay
determin
shown
tabl
assay
detect
pneumonia
refer
strain
test
assay
also
detect
invas
clinic
isol
n
streptococcu
nonstreptococcu
speci
test
none
detect
either
assay
indic
analyt
specif
assay
tabl
fig
genom
dna
serial
dilut
ge
per
reaction
water
subject
rpa
initi
experi
suggest
rpa
capabl
detect
ge
per
reaction
fig
subsequ
analyt
limit
detect
rpa
realtim
pcr
assay
measur
test
replic
serial
dilut
genom
dna
pneumonia
type
strain
dsm
analyt
limit
detect
confid
level
rpa
pcr
assay
establish
ge
per
reaction
respect
tabl
outlin
number
reaction
produc
posit
result
templat
quantiti
degre
rpa
reaction
inhibit
presenc
human
dna
concentr
depend
vari
signific
inhibit
ng
data
shown
substanti
inhibit
presenc
ng
human
dna
highest
test
whilst
inhibit
spike
ng
ng
human
dna
pneumonia
ge
detect
produc
signal
neg
control
reaction
fig
pcr
reaction
spike
human
dna
ngreaction
discern
shift
thresholdcycl
spike
nonspik
reaction
indic
pcr
inhibit
presenc
human
dna
data
shown
abil
assay
detect
pneumonia
spike
whole
blood
healthi
volunt
also
determin
plate
count
indic
cfu
spike
blood
upon
extract
total
dna
elut
subject
rpa
pcr
mean
reaction
contain
templat
genom
dna
cfu
equival
rpa
pcr
assay
detect
cfu
equival
per
reaction
fig
lower
quantiti
cfu
detect
eleven
blood
sampl
confirm
cultur
posit
pneumonia
subject
analysi
rpa
pcr
rpa
pcr
assay
posit
sampl
test
tabl
remain
pneumonia
posit
sampl
purifi
dna
subsequ
test
rpa
pcr
assay
result
posit
signal
figur
show
repres
rpa
amplif
curv
result
dna
purifi
confirm
posit
clinic
blood
sampl
rpa
pcr
analysi
dna
extract
blood
four
healthi
cultur
neg
volunt
produc
neg
result
polysaccharid
capsular
type
serotyp
pneumonia
identifi
introduct
recent
conjug
vaccin
associ
dramat
reduct
number
death
particularli
amongst
children
adult
via
herd
effect
due
pneumococc
infect
howev
pneumococc
diseas
remain
seriou
diseas
global
particularli
children
less
two
year
old
elderli
year
immunocompromis
individu
thu
robust
diagnost
assay
capabl
rapid
sensit
specif
detect
pneumonia
nearpati
set
could
play
signific
role
reduct
pneumococc
diseas
relat
morbid
mortal
particularli
develop
countri
isotherm
vitro
nucleic
acid
amplif
strategi
great
interest
molecular
diagnost
negat
need
thermocycl
case
pcr
pcr
thermocycl
requir
facilit
separ
doublestrand
dna
enabl
amplif
major
isotherm
amplif
techniqu
current
utilis
includ
nucleic
acid
sequenc
base
amplif
nasba
transcript
mediat
amplif
tma
loopmedi
isotherm
amplif
lamp
helicas
depend
amplif
hda
roll
circl
amplif
rca
strand
displac
amplif
sda
nasba
tma
rca
sda
consid
truli
isotherm
requir
initi
heat
step
denatur
target
nucleic
acid
prior
amplif
rpa
hda
lamp
consid
truli
isotherm
requir
denatur
step
initi
amplif
oper
temperatur
lamp
typic
temperatur
nucleic
acid
target
dynam
equilibrium
enabl
bind
primer
target
sequenc
subsequ
amplif
whilst
lamp
inexpens
perform
primer
design
complex
multiplex
amplif
present
difficult
hda
rpa
use
protein
facilit
bind
primer
respect
templat
technolog
enabl
multiplex
amplif
major
advantag
rpa
compet
isotherm
amplif
technolog
speed
capabl
amplifi
singledigit
copi
number
nucleic
acid
detect
level
minut
studi
develop
realtim
rpa
realtim
pcr
assay
detect
pneumonia
use
primer
probe
target
lepa
gene
examin
abil
assay
detect
pneumonia
spike
human
whole
blood
final
appli
assay
detect
pneumonia
directli
blood
patient
confirm
posit
infect
blood
cultur
rpa
pcr
assay
highli
specif
laboratori
strain
n
clinic
isol
pneumonia
n
posit
identifi
assay
neg
non
pneumonia
organ
n
assay
data
support
result
silico
analysi
demonstr
lepa
gene
suffici
sequenc
heterogen
enabl
specif
detect
pneumonia
probit
regress
analysi
use
calcul
confid
analyt
lod
assay
rpa
assay
margin
better
lod
pcr
assay
ge
respect
assum
poisson
distribut
assay
demonstr
limit
detect
approach
molecul
sensit
lod
theoret
possibl
also
note
rpa
reaction
perform
volum
greater
pcr
reaction
suggest
reduc
reaction
volum
therebi
increas
effect
concentr
initi
templat
dna
assay
sensit
could
improv
rpa
rapid
isotherm
vitro
nucleic
acid
amplif
technolog
pneumonia
ge
use
templat
amplif
rpa
assay
produc
posit
signal
littl
min
contrast
cycl
approxim
requir
produc
posit
signal
pcr
assay
equival
templat
quantiti
prior
perform
spike
experi
investig
affect
presenc
background
human
dna
rpa
assay
perform
found
presenc
ng
background
dna
highest
quantiti
test
although
consider
inhibit
rpa
assay
capabl
detect
ge
give
signal
templat
control
reaction
presenc
ng
background
human
dna
rpa
assay
also
inhibit
much
lesser
degre
presenc
ng
dna
accord
dna
extract
kit
manufactur
qiagen
typic
yield
genom
dna
obtain
mammalian
blood
dna
use
inhibit
studi
extract
use
dneasi
blood
tissu
kit
yield
rang
data
shown
assum
averag
yield
dna
blood
consid
elut
extract
dna
subject
rpa
quantiti
background
human
dna
rpa
reaction
approxim
ng
also
test
effect
background
human
dna
pcr
assay
found
reaction
inhibit
even
presenc
ng
background
dna
spike
whole
blood
pcr
rpa
assay
capabl
detect
cfureact
equal
cfu
blood
reaction
blood
spike
experi
perform
duplic
subsequ
repeat
verifi
result
peter
et
al
develop
realtim
pcr
assay
target
autolysin
gene
capabl
detect
equival
cfu
ml
whole
blood
note
cfu
estim
number
viabl
organ
present
cfu
metric
account
presenc
dead
nonviabl
cell
organ
tend
form
clump
grow
pair
chain
may
well
substanti
underestim
number
live
cell
sampl
evalu
rpa
assay
test
small
number
pneumonia
cultur
posit
n
cultur
neg
obtain
consent
volunt
blood
sampl
n
cultur
posit
sampl
result
posit
signal
analys
rpa
pcr
amplif
four
cultur
neg
sampl
rpa
pcr
neg
eight
cultur
posit
sampl
produc
posit
signal
rpa
pcr
test
purifi
dna
remain
three
test
neg
use
purifi
dna
test
use
purifi
dna
assay
assay
produc
posit
signal
result
hint
reduc
bacteri
dna
load
presenc
rpa
pcr
reaction
inhibitor
cultur
posit
sampl
question
may
result
lower
bacteri
cell
load
sampl
dna
degrad
due
extend
sampl
process
time
sampl
acquisit
develop
sensit
specif
realtim
rpa
realtim
pcr
assay
detect
pneumonia
clinic
blood
sampl
shown
assay
specif
sensit
pcr
appli
detect
pneumonia
use
lepa
gene
diagnost
target
assay
may
find
util
rapid
pointofcar
diagnost
test
detect
pneumonia
futur
work
focu
develop
intern
amplif
control
assay
increas
number
clinic
sampl
fulli
valid
rpa
assay
